NCT07052110 DST in Reducing Depressive Symptoms, Enhancing Self-esteem, and Promoting Quality of Life Among CCSs
| NCT ID | NCT07052110 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Hong Kong Polytechnic University |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 248 participants |
| Start Date | 2023-10-16 |
| Primary Completion | 2026-09-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 248 participants in total. It began in 2023-10-16 with a primary completion date of 2026-09-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to examine the effectiveness of Digital storytelling (DST) in reducing depressive symptoms, enhancing self-esteem, and promoting quality of life among Chinese survivors of childhood cancer. Participants in the experimental group will be divided into groups of 6 to 8 childhood cancer survivors to receive the intervention, which comprises four workshops. Each workshop will last 2.5 hours and will be conducted by a qualified interventionist. Parents are not required to attend the workshop. The investigators will provide a waiting room for them. Parents will also be provided with a leaflet developed by Hong Kong Department of Health which contains self-help material for depression. No intervention will be carried out among participants in the control group. However, customary care including medical follow-up, medication prescription, and nursing interventions will be provided, as usual. Parents will also be provided with a leaflet containing self-help materials for depression.
Eligibility Criteria
Inclusion Criteria: * (1) age between 13 and 18 years; * (2) able to speak Cantonese and read Chinese; and * (3) completed the active treatment of cancer. Exclusion Criteria: * survivors with mental and behavioural problems documented in their medical records.
Contact & Investigator
Ka Yan Ho, phd
PRINCIPAL INVESTIGATOR
The Hong Kong Polytechnic University
Frequently Asked Questions
Who can join the NCT07052110 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 18 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07052110 currently recruiting?
Yes, NCT07052110 is actively recruiting participants. Contact the research team at kyeva.ho@polyu.edu.hk for enrollment information.
Where is the NCT07052110 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07052110 clinical trial?
NCT07052110 is sponsored by The Hong Kong Polytechnic University. The principal investigator is Ka Yan Ho, phd at The Hong Kong Polytechnic University. The trial plans to enroll 248 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.